Navigation Links
Best Practices, LLC Research Highlights Critical Role of Medical Affairs in New Product Launch Success
Date:1/14/2011

CHAPEL HILL, N.C., Jan. 14, 2011 /PRNewswire/ -- New Product Planning (NPP) groups play a vital role in many of the new product development activities that set the stage for a successful launch. One of the areas of growing importance for NPP groups is medical affairs activities such as ad boards, and thought leader identification and education.

The Best Practices, LLC benchmarking report New Product Planning: Role and Activities for Medical Affairs provides a detailed examination of the timing and value of Medical Affairs activities.

Key chapters in this 50-slide report are:

  • The current state of New Product Planning in pharma 

The central challenge is to ensure that the right new products get developed efficiently—with minimum risk and maximum value—to allow senior management to make smart decisions confidently.  

  • Overview of New Product Planning activities and timing during development process

Reviews Key Patterns and Activities that drive the New Product Planning process

Pre-clinical through Phase II: NPP engages in a series of activities from Pre-Clinical through Phase 2 designed to determine the market fit and potential of identified candidates and to prepare for key activities, such as positioning and branding.

Phase III through Commercial Handoff: After Phase II, NPP activities are more focused as more clinical data becomes available and outputs are refined to support critical commercial activities and maximize the product's launch and lifecycle success.  

This chapter also reviews the main Medical Affairs activities carried out during the development process - analysis provides drill down for each of these activities in terms of their timing, intended outcomes, and value for the organization

  • Advisory Boards
  • Branding of the Science
  • KOL Identification
  • KOL Management
  • Medical Meeting Planning
  • Non-Registration Trials Strategy and Planning
  • Publication Strategy & Planning  

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1038.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research from Best Practices, LLC can Improve Formulary Access and Product Placement for Biopharma Companies: Managed Markets Market Research
2. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
3. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
4. Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups
5. Best Practices, LLC Report on Post-Marketing Surveillance Programs Sheds Light on Gray Areas of Adverse Event Reporting
6. Best Practices, LLC Research Highlights Critical Role of Medical Marketing in New Product Launch Success
7. Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success
8. Research from Best Practices, LLC Delivers Effective Market Education Tactics and Strategies for New Oncology Products
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):